Astellas has appointed Shontelle Dodson as its new senior vice president and head of Medical Affairs Americas (MAA) to lead the strategic direction of its MAA organisation including continued medical support of in-line products, late-stage development compounds and ongoing business evolution across the region.
Dodson has previously led the alignment of medical affairs practices, policies and standards at Astellas, and she has taken on projects such as expanding the Health Economics and Outcomes Research function, pioneered multiple real-world data endeavours and built research partnerships with academic and managed care organisations.
Charlotte Kremer, Astellas’ executive vice president and head of medical affairs, said: “Shontelle has been an integral and formative leader in the building and evolution of the Medical Affairs organisation at Astellas.”
“I’m confident she will make an immediate and positive impact on both the team in the Americas, as well as the patients and partners we serve.”
Dodson has previously worked for Pfizer in various medical affairs leadership roles spanning the urology and respiratory franchises and has served GTx as its vice president of medical affairs.
She has also received multiple awards for leadership and innovation through her career, including the National Healthcare Business Women’s Association Rising Star and the Astellas Vision Award.